Cargando…
P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431262/ http://dx.doi.org/10.1097/01.HS9.0000846484.91738.d2 |
| _version_ | 1784780005147934720 |
|---|---|
| author | Gao, Y.-J. Shen, K.-N. Chang, L. Feng, J. Zhang, L. Mao, Y.-Y. Cao, X.-X. Zhou, D.-B. Li, J. |
| author_facet | Gao, Y.-J. Shen, K.-N. Chang, L. Feng, J. Zhang, L. Mao, Y.-Y. Cao, X.-X. Zhou, D.-B. Li, J. |
| author_sort | Gao, Y.-J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431262 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312622022-08-31 P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY Gao, Y.-J. Shen, K.-N. Chang, L. Feng, J. Zhang, L. Mao, Y.-Y. Cao, X.-X. Zhou, D.-B. Li, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431262/ http://dx.doi.org/10.1097/01.HS9.0000846484.91738.d2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Gao, Y.-J. Shen, K.-N. Chang, L. Feng, J. Zhang, L. Mao, Y.-Y. Cao, X.-X. Zhou, D.-B. Li, J. P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_full | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_fullStr | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_full_unstemmed | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_short | P903: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY |
| title_sort | p903: daratumumab plus bortezomib and dexamethasone in newly diagnosed patients with mayo 2004 stage 3 light-chain amyloidosis: a prospective phase 2 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431262/ http://dx.doi.org/10.1097/01.HS9.0000846484.91738.d2 |
| work_keys_str_mv | AT gaoyj p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT shenkn p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT changl p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT fengj p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT zhangl p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT maoyy p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT caoxx p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT zhoudb p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study AT lij p903daratumumabplusbortezomibanddexamethasoneinnewlydiagnosedpatientswithmayo2004stage3lightchainamyloidosisaprospectivephase2study |